TGTX•benzinga•
TG Therapeutics Expects Full Year 2025 Revenue Of Approximately $540M Versus Consensus Of $548.20M, Including Briumvi U.S. Net Product Revenue Of Approximately $525M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 3, 2025 by benzinga